Journal of Hematopathology

, Volume 6, Issue 1, pp 25–32

Donor-derived isolated del(20q) after hematopoietic stem cell transplantation: report of two cases and review of the literature

  • Rashmi Kanagal-Shamanna
  • Carlos E. Bueso-Ramos
  • Su S. Chen
  • Lynne V. Abruzzo
  • Marcos J. de Lima
  • Rachel L. Sargent
  • L. Jeffrey Medeiros
  • Gary Lu
Case Report

References

  1. 1.
    Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Bornhauser M, Niederwieser D, Ruutu T (2005) Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 90:969–975PubMedGoogle Scholar
  2. 2.
    Boulton-Jones R, Parker A, Hepburn M, Bowen DT (2005) Secondary myelodysplasia of donor cell origin following nonmyeloablative sibling allogeneic stem cell transplantation. Bone Marrow Transplant 36:471–472PubMedCrossRefGoogle Scholar
  3. 3.
    Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM (2004) Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review. Am J Hematol 76:389–394PubMedCrossRefGoogle Scholar
  4. 4.
    Shekhter-Levin S, Bloom EJ, Swerdlow SH, Sherer ME, Wald N, Gollin SM (1997) Acquired monosomy 7 in donor cells in a patient treated for acute lymphoblastic leukemia with bone marrow transplantation. Cancer Genet Cytogenet 95:190–197PubMedCrossRefGoogle Scholar
  5. 5.
    Lowsky R, Fyles G, Minden M, Lipton J, Meharchand J, Tejpar I, Zipursky A, Messner H (1996) Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol 93:163–165PubMedCrossRefGoogle Scholar
  6. 6.
    Abeliovich D, Yehuda O, Nagler A, Lerer I, Ben-Neriah S, Amar A, Or R (1996) Predominant 45, X,—Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis. Cancer Genet Cytogenet 86:1–7PubMedCrossRefGoogle Scholar
  7. 7.
    Okamoto T, Kanamaru A, Okada M, Kawaguchi K, Saheki K, Takatsuka H, Fujimori Y, Takemoto Y, Kohsaki M, Kakishita E (1996) Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation. Int J Hematol 63:155–160PubMedCrossRefGoogle Scholar
  8. 8.
    Sevilla J, Querol S, Molines A, Gonzalez-Vicent M, Balas A, Carrio A, Estella J, Angel Diaz M, Madero L (2006) Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol 77:259–263PubMedCrossRefGoogle Scholar
  9. 9.
    Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM (2002) Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 29:999–1003PubMedCrossRefGoogle Scholar
  10. 10.
    Daly AS, Kamel-Reid S, Lipton JH, Messner HA, Kiss TL, Chun K, Busque L, Chang H (2004) Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Leuk Res 28:1107–1111PubMedCrossRefGoogle Scholar
  11. 11.
    Lang Z, Dinndorf P, Ladisch S, Bayever E, Reaman G (2004) Chromosomal transformation in donor cells following allogeneic bone marrow transplantation. Bone Marrow Transplant 33:1253–1256PubMedCrossRefGoogle Scholar
  12. 12.
    Kraut L, Trebeljahr G, Thiele B, Fauser AA (2005) Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph + chronic myeloid leukemia. Bone Marrow Transplant 36:737PubMedCrossRefGoogle Scholar
  13. 13.
    Beck C, Humpe A, Harder S, Schmid M, Horst HA (2005) Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient. Ann Hematol 84:616–618PubMedCrossRefGoogle Scholar
  14. 14.
    Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman SJ, Deeg HJ, Radich JP (2006) Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:511–517PubMedCrossRefGoogle Scholar
  15. 15.
    Wang E, Hutchinson CB, Huang Q, Lu CM, Crow J, Wang FF, Sebastian S, Rehder C, Lagoo A, Horwitz M, Rizzieri D, Yu J, Goodman B, Datto M, Buckley P (2011) Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol 135:525–540PubMedCrossRefGoogle Scholar
  16. 16.
    Erdag G, Meck JM, Meloni-Ehrig A, Matyakhina L, Donohue T, Srinivasan R, Mowrey P, Kelly J, Smith A, Childs R (2009) Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation. Cancer Genet Cytogenet 190:125–130PubMedCrossRefGoogle Scholar
  17. 17.
    Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP (2011) Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 49:390–399Google Scholar
  18. 18.
    Sole F, Luno E, Sanzo C, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Cigudosa JC, Milla F, Ribera JM, Bureo E, Marquez ML, Arranz E, Florensa L (2005) Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 90:1168–1178PubMedGoogle Scholar
  19. 19.
    Gupta R, Soupir CP, Johari V, Hasserjian RP (2007) Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation. Br J Haematol 139:265–268PubMedCrossRefGoogle Scholar
  20. 20.
    Steensma DP, Dewald GW, Hodnefield JM, Tefferi A, Hanson CA (2003) Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res 27:235–242PubMedCrossRefGoogle Scholar
  21. 21.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissue 4th edn. IARC, LyonGoogle Scholar
  22. 22.
    Tiu RV, Sekeres MA (2008) (2008) The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes. Expert Opin Biol Ther 8(7):1021–1030PubMedCrossRefGoogle Scholar
  23. 23.
    Hao S, Sanger W, Onciu M, Lai R, Schlette EJ, Medeiros LJ (2002) Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 15:1266–1272PubMedCrossRefGoogle Scholar
  24. 24.
    Shaffer LG, Slovak ML, Campbell LJ (2009) An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature S. Karger AG (Switzerland)Google Scholar
  25. 25.
    Sun J, Yin CC, Cui W, Chen SS, Medeiros LJ, Lu G (2011) Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol 135:391–397PubMedCrossRefGoogle Scholar
  26. 26.
    Fialkow PJ, Thomas ED, Bryant JI, Neiman PE (1971) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1:251–255PubMedCrossRefGoogle Scholar
  27. 27.
    Murata M, Ishikawa Y, Ohashi H, Terakura S, Ozeki K, Kiyoi H, Naoe T (2008) Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review. Int J Hematol 88:111–115PubMedCrossRefGoogle Scholar
  28. 28.
    Wiseman DH (2011) Donor cell leukemia: a review. Biol Blood Marrow Transplant 17:771–789PubMedCrossRefGoogle Scholar
  29. 29.
    Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C (2009) Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Ann Hematol 88:1207–1213PubMedCrossRefGoogle Scholar
  30. 30.
    Reid AG, Swanton S, Grace C, Campbell LJ, Green AR, Nacheva EP (2003) Double Philadelphia masquerading as chromosome 20q deletion—a new recurrent abnormality in chronic myeloid leukaemia blast crisis. Br J Haematol 123:442–448PubMedCrossRefGoogle Scholar
  31. 31.
    Medina J, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Giles F, Rios MB, Hayes K, Cortes J (2003) Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Cancer 98:1905–1911PubMedCrossRefGoogle Scholar
  32. 32.
    Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S, Shan J, Rios MB, Cortes J (2007) Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 110:2991–2995PubMedCrossRefGoogle Scholar
  33. 33.
    Medeiros BC, Chun K, Kamel-Reid S, Lipton J (2007) Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation. Am J Hematol 82:758–760PubMedCrossRefGoogle Scholar
  34. 34.
    Kurtin PJ, Dewald GW, Shields DJ, Hanson CA (1996) Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients. Am J Clin Pathol 106:680–688PubMedGoogle Scholar
  35. 35.
    Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewicz JA, Thaler J, Huber C (1990) Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 322:1794–1796PubMedCrossRefGoogle Scholar
  36. 36.
    Dykes JH, Lindmark A, Lenhoff S, Winqvist I, Johansson B, Olofsson T, Olsson ML (2004) Autologous del(20q)-positive erythroid progenitor cells, re-emerging after DLI treatment of an MDS patient relapsing after allo-SCT, can provide a normal peripheral red blood cell count. Bone Marrow Transplant 33:559–563PubMedCrossRefGoogle Scholar
  37. 37.
    Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R (1999) Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation. Br J Haematol 105:361–365PubMedCrossRefGoogle Scholar
  38. 38.
    Mielcarek M, Bryant E, Loken M, Zaucha JM, Torok-Storb B, Storb R (2006) Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation. Blood 107:1732–1733PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Rashmi Kanagal-Shamanna
    • 1
  • Carlos E. Bueso-Ramos
    • 1
  • Su S. Chen
    • 1
  • Lynne V. Abruzzo
    • 1
  • Marcos J. de Lima
    • 1
  • Rachel L. Sargent
    • 1
  • L. Jeffrey Medeiros
    • 1
  • Gary Lu
    • 1
    • 2
  1. 1.Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations